Literature DB >> 8061024

Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation.

P A Tucker1, B S Jin, C M Gaos, B Radovancevic, O H Frazier, S Wilansky.   

Abstract

Flail tricuspid leaflet has been reported as a relatively uncommon complication of endomyocardial biopsy in orthotopic heart transplant recipients. However, the relationship of this complication to the number of biopsies performed and to the site of access for biopsy is not known. The objectives of this study were to assess the prevalence of flail tricuspid leaflet/torn chordae tendineae in our recent transplant population, define the relationship of this complication to endomyocardial biopsy, and to correlate echocardiographic assessments of tricuspid regurgitation severity with hemodynamic data obtained at cardiac catheterization. From January 1991 to March 1993, 181 patients who had undergone orthotopic heart transplantation at our institution were evaluated with echocardiography for the presence of a flail leaflet or torn chordae tendineae of the tricuspid valve and tricuspid regurgitation. After identifying this complication in patients, we reviewed their hemodynamic tracings and biopsy protocols from the catheterization laboratory. The hemodynamic tracing chosen was that which was done at the time the flail leaflet was first diagnosed. Of the 181 patients, 21 (11.6%) had flail leaflet or torn chordae tendineae of the tricuspid valve. The group comprised 18 male and 3 female patients. The mean duration from the time of transplantation was 42 months (range, 1 to 87 months). The mean number of biopsies performed per patient was 15.5 (range, 2 to 27). The mean severity of tricuspid regurgitation by echocardiography was grade 3 (moderate); seven patients (33%) had severe regurgitation. The mean right atrial v wave by catheterization was 15 mm Hg (range, 6 to 26 mm Hg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8061024

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Authors:  Juyup Han; Yongwhi Park; Hyunsang Lee; Hyunjae Kang; Hyungseop Kim; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

2.  Impact of vascular access site on procedural time of endomyocardial biopsy.

Authors:  Kentaro Mukai; Yusuke Nakano; Tomofumi Mizuno; Toru Niwa; Hirokazu Wakabayashi; Akihiro Suzuki; Atsushi Watanabe; Hirohiko Ando; Kenta Murotani; Katsuhisa Waseda; Tetsuya Amano
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

3.  Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures.

Authors:  Se Yong Jang; Yongkeun Cho; Joon Hyuck Song; Sang Soo Cheon; Sun Hee Park; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Shung Chull Chae
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

Review 4.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

5.  Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice.

Authors:  Filip K Swirski; Moritz Wildgruber; Takuya Ueno; Jose-Luiz Figueiredo; Peter Panizzi; Yoshiko Iwamoto; Elizabeth Zhang; James R Stone; Elisenda Rodriguez; John W Chen; Mikael J Pittet; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

6.  Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.

Authors:  Takuya Ueno; Partha Dutta; Edmund Keliher; Florian Leuschner; Maulik Majmudar; Brett Marinelli; Yoshiko Iwamoto; Jose-Luiz Figueiredo; Thomas Christen; Filip K Swirski; Peter Libby; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Cardiovasc Imaging       Date:  2013-06-14       Impact factor: 7.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.